{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:20:17Z","timestamp":1781950817321,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[1997,8,19]]},"abstract":"<jats:p>\n            <jats:italic>Background<\/jats:italic>\n            Aurintricarboxylic acid (ATA) prevents von Willebrand factor binding to platelet glycoprotein (GP) Ib, with higher-molecular-weight ATA more effective than the lower-molecular-weight compound. We investigated the effects of high-molecular-weight ATA (\n            <jats:italic>M<\/jats:italic>\n            <jats:sub>r<\/jats:sub>\n            =7500), obtained by fractionating commercial ATA, in the injured hamster carotid artery.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Methods and Results<\/jats:italic>\n            Platelet aggregation was induced in vitro with ADP (2.5 \u03bcmol\/L) or botrocetin (5 \u03bcg\/mL) in hamster platelet-rich plasma. IC\n            <jats:sub>50<\/jats:sub>\n            values were 348.6\u00b122.4 and 8.2\u00b13.2 \u03bcg\/mL, respectively. The endothelium of hamster carotid artery was denuded with a modified catheter. Continuous administration of high-molecular-weight ATA (10, 30, and 100 \u03bcg\u00b7kg\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7h\n            <jats:sup>\u22121<\/jats:sup>\n            ) with an infusion pump produced antithrombotic effects in a dose-dependent manner, as evaluated by prolongation of time to occlusion. Neointima formation was observed 2 weeks after catheterization, and proliferating smooth muscle cells (SMCs) were identified by the thymidine analogue 5-bromo-2-deoxy-uridine (BrdU). Continuous treatment with the compound (100 \u03bcg\u00b7kg\n            <jats:sup>\u22121<\/jats:sup>\n            \u00b7h\n            <jats:sup>\u22121<\/jats:sup>\n            ) with a 2ML1 Alzet infusion pump resulted in a reduction of neointimal area by 38.0\u00b18.8% and decreased the BrdU index on days 1 and 7 significantly. DNA synthesis in DDT1MF2 hamster SMCs was also decreased by the compound in a dose-dependent manner. In histological observation, the process of endothelial healing was improved by this treatment with the compound.\n          <\/jats:p>\n          <jats:p>\n            <jats:italic>Conclusions<\/jats:italic>\n            Inhibition of platelet adhesion by von Willebrand factor binding to platelet GP Ib by high-molecular-weight ATA results in the prevention of thrombus formation and the suppression of neointima lesion. In addition, high-molecular-weight ATA has an inhibitory effect on SMC proliferation. This inhibition of both platelet adhesion and SMC proliferation markedly reduced vascular stenosis.\n          <\/jats:p>","DOI":"10.1161\/01.cir.96.4.1299","type":"journal-article","created":{"date-parts":[[2012,6,12]],"date-time":"2012-06-12T00:41:02Z","timestamp":1339461662000},"page":"1299-1304","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Inhibition of von Willebrand Factor Binding to Platelet GP Ib by a Fractionated Aurintricarboxylic Acid Prevents Restenosis After Vascular Injury in Hamster Carotid Artery"],"prefix":"10.1161","volume":"96","author":[{"given":"Hiroyuki","family":"Matsuno","sequence":"first","affiliation":[{"name":"From the Department of Pharmacology, Gifu University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Kozawa","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Gifu University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Niwa","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Gifu University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Uematsu","sequence":"additional","affiliation":[{"name":"From the Department of Pharmacology, Gifu University School of Medicine, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V70.5.1577.1577"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1647271"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113602"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V67.5.1356.1356"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V61.1.99.99"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115124"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/atv91.11.5.1655016"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V72.6.1898.1898"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.81.3.2306818"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114757"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.10.2603.2603"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.90.5.7955174"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470103"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.9.2291.2291"},{"key":"e_1_3_2_15_2","unstructured":"Haugwitz R. New anti-HIV compounds belonging to aurintricarboxylic acid. US Patent 7431568 1989."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649987"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1992.tb14370.x"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116085"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650566"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0160-5402(91)90030-9"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1653454"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(05)80335-6"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1650243"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1656006"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/atv91.14.12.7981190"}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.CIR.96.4.1299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:20:57Z","timestamp":1715530857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.CIR.96.4.1299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8,19]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1997,8,19]]}},"alternative-id":["10.1161\/01.CIR.96.4.1299"],"URL":"https:\/\/doi.org\/10.1161\/01.cir.96.4.1299","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8,19]]},"assertion":[{"value":"1996-12-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-02-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1997-08-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}